The Effect of Associated Parkinsonism on Rehabilitation in Stroke Patients: A Case Series

Yıl: 2018 Cilt: 52 Sayı: 1 Sayfa Aralığı: 64 - 69 Metin Dili: İngilizce İndeks Tarihi: 29-07-2022

The Effect of Associated Parkinsonism on Rehabilitation in Stroke Patients: A Case Series

Öz:
Stroke and Parkinson's disease are 2 major causes of movement impairment and a decreased ability to perform daily activities. The aim of this case series was to demonstrate the difficulty of rehabilitation in stroke patients with accompanying parkinsonism. Four stroke patients with parkinsonism who underwent rehabilitation at the Physical Medicine and Rehabilitation Clinic between March and May of 2016 were evaluated. The Standardized Mini-Mental State Examination (SMMSE), the Functional Independence Measure (FIM), the Barthel Index (BI), the Berg Balance Scale (BBS), and the Stroke Impact Scale version 3.0 (SIS) were used in the assessment. Of the 4 patients, 3 were female, and the mean age was 74.5±9.3 years. The mean hospital stay was 19±5.3 days. The initial test scores recorded were low, and they remained low at the time of discharge. After rehabilitation, the mean FIM score in the group was 42% of the maximum possible score, the mean SMMSE was 55%, the BI was 18%, the BBS was 0.08%, and the SIS was 25%. Three patients required a wheelchair, and 1 patient could ambulate with a walker at discharge. A stroke accompanied by parkinsonism negatively affects mobility and functional status, primarily through the deterioration of balance. In this study, cognitive function was reduced to half of the maximum, and the balance and function loss was more than 50%. Barthel index; berg balance scale; functional independence measure; mini-mental state examination; parkinsonism; stroke; stroke impact scale.
Anahtar Kelime:

Konular: Cerrahi
Belge Türü: Makale Makale Türü: Olgu Sunumu Erişim Türü: Erişime Açık
  • 1. Parkinson J. An essay on the shaking palsy. 1817. J Neuropsychiatry Clin Neurosci 2002;14:223-36.
  • 2. Yavuz BB. Nöropsikiyatrik Değerlendirme ve kullanılan testler. İç Hastalıkları Dergisi 2008;15:5-13.
  • 3. Hüseyinoğlu N, Çelik B. Parkinson Hastalığı Rehabilitasyonu. In: Oğuz H, Çakırbay H, Yanık B, editors. Tıbbi Rehabilitasyon. 3rd. Istanbul: Nobel Tıp Kitabevleri; 2015.p.497-8.
  • 4. Ertan S. Parkinson Hastalığının Klinik Özellikleri. Siva A, Saip S, Kaynak D (Edi-tör) Nörolog Olmayanlar için Nöroloji, Sempozyumu Dizisi 2005;42:249-54.
  • 5. de Lau LM, Breteler MM. Epidemiology of Parkinson's disease. Lancet Neurol 2006;5:525-35.
  • 6. Schrag A, Jahanshahi M, Quinn N. How does Parkinson's disease affect quality of life? A comparison with quality of life in the general population. Mov Disord 2000;15:1112-8.
  • 7. Dontje ML, de Greef MH, Speelman AD, van Nimwegen M, Krijnen WP, Stolk RP, et al. Quantifying daily physical activity and determinants in sedentary patients with Parkinson's disease. Parkinsonism Relat Disord 2013;19:878-82.
  • 8. Lord S, Godfrey A, Galna B, Mhiripiri D, Burn D, Rochester L. Ambulatory activ-ity in incident Parkinson's: more than meets the eye? J Neurol 2013;260:2964-72.
  • 9. Buckley TA, Pitsikoulis C, Hass CJ. Dynamic postural stability during sit-to-walk transitions in Parkinson disease patients. Mov Disord 2008;23:1274-80.
  • 10. Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C, et al.; Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord 2004;19:1020-8.
  • 11. Lang AET, Fahn S. Assessment of Parkinson's Disease. In: Munsat TL, editor. Quantification of Neurologic Deficit. Stoneham, MA: Butterworths, 1989:285-309.
  • 12. Huang YP, Chen LS, Yen MF, Fann CY, Chiu YH, Chen HH, et al. Parkinson's disease is related to an increased risk of ischemic stroke-a population-based propensi-ty score-matched follow-up study. PLoS One 2013;8:e68314.
  • 13. Jenner P. Oxidative stress in Parkinson's disease. Ann Neurol 2003;53 Suppl 3:S26-36.
  • 14. Facecchia K, Fochesato LA, Ray SD, Stohs SJ, Pandey S. Oxidative toxicity in neurodegenerative diseases: role of mitochondrial dysfunction and therapeutic strate-gies. J Toxicol 2011;2011:683728.
  • 15. Gegg ME, Cooper JM, Schapira AH, Taanman JW. Silencing of PINK1 expres-sion affects mitochondrial DNA and oxidative phosphorylation in dopaminergic cells. PLoS One 2009;4:e4756.
  • 16. Harrison D, Griendling KK, Landmesser U, Hornig B, Drexler H. Role of oxida-tive stress in atherosclerosis. Am J Cardiol 2003;91:7A-11A.
  • 17. Glass CK, Witztum JL. Atherosclerosis: The road ahead. Cell 2001;104:503-16.
  • 18. Velseboer DC, de Haan RJ, Wieling W, Goldstein DS, de Bie RM. Prevalence of orthostatic hypotension in Parkinson's disease: a systematic review and meta-analysis. Parkinsonism Relat Disord 2011;17:724-9.
  • 19. Cereda E, Barichella M, Cassani E, Caccialanza R, Pezzoli G. Clinical features of Parkinson disease when onset of diabetes came first: A case-control study. Neurology 2012;78:1507-11.
  • 20. Schernhammer E, Hansen J, Rugbjerg K, Wermuth L, Ritz B. Diabetes and the risk of developing Parkinson's disease in Denmark. Diabetes Care 2011;34:1102-8.
  • 21. Sun Y, Chang YH, Chen HF, Su YH, Su HF, Li CY. Risk of Parkinson disease onset in patients with diabetes: a 9-year population-based cohort study with age and sex stratifications. Diabetes Care 2012;35:1047-9.
  • 22. Cereda E, Barichella M, Pedrolli C, Klersy C, Cassani E, Caccialanza R, et al. Diabetes and risk of Parkinson's disease: a systematic review and meta-analysis. Dia-betes Care 2011;34:2614-23.
  • 23. Qiu C, Hu G, Kivipelto M, Laatikainen T, Antikainen R, Fratiglioni L, et al. As-sociation of blood pressure and hypertension with the risk of Parkinson disease: the National FINRISK Study. Hypertension 2011;57:1094-100.
  • 24. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurolo-gy 1967;17:427-42.
  • 25. Struck LK, Rodnitzky RL, Dobson JK. Stroke and its modification in Parkinson's disease. Stroke 1990;21:1395-9.
  • 26. Kessler II. Epidemiologic studies of Parkinson's disease: A community-based survey. Am J Epidemiol 1972;96:242-54.
  • 27. Eadie Mj, Sutherland Jm. Arteriosclerosis In Parkinsonism. J Neurol Neurosurg Psychiatry 1964;27:237-40.
  • 28. Marttila RJ, Rinne UK. Arteriosclerosis, heredity, and some previous infections in the etiology of Parkinson's disease. A case-control study. Clin Neurol Neurosurg 1976;79:46-56.
  • 29. Godwin-Austen RB, Lee PN, Marmot MG, Stern GM. Smoking and Parkinson's disease. J Neurol Neurosurg Psychiatry 1982;45:577-81.
  • 30. Zervas NT, Lavyne MH, Negoro M. Neurotransmitters and the normal and is-chemic cerebral circulation. N Engl J Med 1975;293:812-6.
  • 31. Globus MY, Ginsberg MD, Dietrich WD, Busto R, Scheinberg P. Substantia nigra lesion protects against ischemic damage in the striatum. Neurosci Lett 1987;80:251-6.
  • 32. Levine RL, Jones JC, Bee N. Stroke and Parkinson's disease. Stroke 1992;23:839-42.
  • 33. Malek N, Lawton MA, Swallow DM, Grosset KA, Marrinan SL, Bajaj N, et al.; PRoBaND Clinical Consortium. Vascular disease and vascular risk factors in relation to motor features and cognition in early Parkinson's disease. Mov Disord 2016;31:1518-1526.
  • 34. Park K, Yasuda N, Toyonaga S, Yamada SM, Nakabayashi H, Nakasato M, et al. Significant association between leukoaraiosis and metabolic syndrome in healthy subjects. Neurology 2007;69:974-8.
  • 35. Vesely B, Rektor I. The contribution of white matter lesions (WML) to Parkin-son's disease cognitive impairment symptoms: A critical review of the literature. Par-kinsonism Relat Disord 2016;22 Suppl 1:S166-70.
  • 36. Chen YF, Tseng YL, Lan MY, Lai SL, Su CS, Liu JS, et al. The relationship of leukoaraiosis and the clinical severity of vascular Parkinsonism. J Neurol Sci 2014;346:255-9.
  • 37. Tomlinson CL, Herd CP, Clarke CE, Meek C, Patel S, Stowe R, et al. Physiother-apy for Parkinson's disease: a comparison of techniques. Cochrane Database Syst Rev 2014;CD002815.
  • 38. Güngen C, Ertan T, Eker E, Yaşar R, Engin F. Reliability and validity of the standardized Mini Mental State Examination in the diagnosis of mild dementia in Turkish population. Turk Psikiyatri Derg 2002;13:273-81.
  • 39. Altun AM, Ozbek SE, Zarifoglu M, Özkaya G. Parkinson Hastalığında yürüme ve dengenin değerlendirilmesi. Parkinson Hastalığı ve Hareket Bozukluğu Dergisi. 2013;16:1-8.
  • 40. Berg KO, Wood-Dauphinee SL, Williams JI, Maki B. Measuring balance in the elderly: validation of an instrument. Can J Public Health 1992;83 Suppl 2:S7-11.
  • 41. Berg K, Wood-Dauphinee S, Williams JI. The Balance Scale: reliability assess-ment with elderly residents and patients with an acute stroke. Scand J Rehabil Med 1995;27:27-36.
  • 42. Sahin F, Yilmaz F, Ozmaden A, Kotevolu N, Sahin T, Kuran B. Reliability and validity of the Turkish version of the Berg Balance Scale. J Geriatr Phys Ther 2008;31:32-7.
  • 43. Şahin F, Büyükavcı R, Sağ S, Doğu B, Kuran B. Berg Denge Ölçeği'nin Türkçe versiyonunun inmeli hastalarda geçerlilik ve güvenilirliği. Türk Fiz Tıp Rehab Derg 2013;59:170-5.
  • 44. Küçükdeveci AA, Yavuzer G, Elhan AH, Sonel B, Tennant A. Adaptation of the Functional Independence Measure for use in Turkey. Clin Rehabil 2001;15:311-9.
  • 45. Mahoney Fi, Barthel Dw. Functional Evaluation: The Barthel Index. Md State Med J 1965;14:61-5.
  • 46. Nichols-Larsen DS, Clark PC, Zeringue A, Greenspan A, Blanton S. Factors in-fluencing stroke survivors' quality of life during subacute recovery. Stroke 2005;36:1480-4.
  • 47. Duncan PW, Bode RK, Min Lai S, Perera S; Glycine Antagonist in Neuroprotec-tion Americans Investigators. Rasch analysis of a new stroke-specific outcome scale: the Stroke Impact Scale. Arch Phys Med Rehabil. 2003;84:950-63.
  • 48. Lai SM, Studenski S, Duncan PW, Perera S. Persisting consequences of stroke measured by the Stroke Impact Scale. Stroke 2002;33:1840-4.
  • 49. Hantal AÖ, Doğu B, Büyükavcı R, Kuran B. İnme Etki Ölçeği 3,0: Türk toplu-mundaki inmeli hastalarda güvenilirlik ve geçerlilik çalışması. Türk Fiz Tıp Rehab Derg 2014;60:106-16.
  • 50. Mahieux F, Michelet D, Manifacier MJ, Boller F, Fermanian J, Guillard A. Mini-Mental Parkinson: first validation study of a new bedside test constructed for Parkin-son's disease. Behav Neurol 1995;8:15-22.
  • 51. Ozdilek B, Kenangil G. Validation of the Turkish Version of the Montreal Cogni-tive Assessment Scale (MoCA-TR) in patients with Parkinson's disease. Clin Neuro-psychol 2014;28:333-43.
  • 52. Qutubuddin AA, Pegg PO, Cifu DX, Brown R, McNamee S, Carne W. Validating the Berg Balance Scale for patients with Parkinson's disease: a key to rehabilitation evaluation. Arch Phys Med Rehabil 2005;86:789-92.
APA çiftci s, KURAN K, DUMAN Z, Yilmaz F, MERT C, durlanık g, ÖNCÜ J, DÜDEN B, BERTAN H, ERÇALIK C, DOĞU B, Terlemez R (2018). The Effect of Associated Parkinsonism on Rehabilitation in Stroke Patients: A Case Series. , 64 - 69.
Chicago çiftci selda,KURAN KADRİYE BANU,DUMAN Zehra,Yilmaz Figen,MERT Cansu,durlanık gülgün,ÖNCÜ Jülide,DÜDEN Bilge,BERTAN Hüseyin,ERÇALIK CEM,DOĞU BERİL,Terlemez Rana The Effect of Associated Parkinsonism on Rehabilitation in Stroke Patients: A Case Series. (2018): 64 - 69.
MLA çiftci selda,KURAN KADRİYE BANU,DUMAN Zehra,Yilmaz Figen,MERT Cansu,durlanık gülgün,ÖNCÜ Jülide,DÜDEN Bilge,BERTAN Hüseyin,ERÇALIK CEM,DOĞU BERİL,Terlemez Rana The Effect of Associated Parkinsonism on Rehabilitation in Stroke Patients: A Case Series. , 2018, ss.64 - 69.
AMA çiftci s,KURAN K,DUMAN Z,Yilmaz F,MERT C,durlanık g,ÖNCÜ J,DÜDEN B,BERTAN H,ERÇALIK C,DOĞU B,Terlemez R The Effect of Associated Parkinsonism on Rehabilitation in Stroke Patients: A Case Series. . 2018; 64 - 69.
Vancouver çiftci s,KURAN K,DUMAN Z,Yilmaz F,MERT C,durlanık g,ÖNCÜ J,DÜDEN B,BERTAN H,ERÇALIK C,DOĞU B,Terlemez R The Effect of Associated Parkinsonism on Rehabilitation in Stroke Patients: A Case Series. . 2018; 64 - 69.
IEEE çiftci s,KURAN K,DUMAN Z,Yilmaz F,MERT C,durlanık g,ÖNCÜ J,DÜDEN B,BERTAN H,ERÇALIK C,DOĞU B,Terlemez R "The Effect of Associated Parkinsonism on Rehabilitation in Stroke Patients: A Case Series." , ss.64 - 69, 2018.
ISNAD çiftci, selda vd. "The Effect of Associated Parkinsonism on Rehabilitation in Stroke Patients: A Case Series". (2018), 64-69.
APA çiftci s, KURAN K, DUMAN Z, Yilmaz F, MERT C, durlanık g, ÖNCÜ J, DÜDEN B, BERTAN H, ERÇALIK C, DOĞU B, Terlemez R (2018). The Effect of Associated Parkinsonism on Rehabilitation in Stroke Patients: A Case Series. Şişli Etfal Hastanesi Tıp Bülteni, 52(1), 64 - 69.
Chicago çiftci selda,KURAN KADRİYE BANU,DUMAN Zehra,Yilmaz Figen,MERT Cansu,durlanık gülgün,ÖNCÜ Jülide,DÜDEN Bilge,BERTAN Hüseyin,ERÇALIK CEM,DOĞU BERİL,Terlemez Rana The Effect of Associated Parkinsonism on Rehabilitation in Stroke Patients: A Case Series. Şişli Etfal Hastanesi Tıp Bülteni 52, no.1 (2018): 64 - 69.
MLA çiftci selda,KURAN KADRİYE BANU,DUMAN Zehra,Yilmaz Figen,MERT Cansu,durlanık gülgün,ÖNCÜ Jülide,DÜDEN Bilge,BERTAN Hüseyin,ERÇALIK CEM,DOĞU BERİL,Terlemez Rana The Effect of Associated Parkinsonism on Rehabilitation in Stroke Patients: A Case Series. Şişli Etfal Hastanesi Tıp Bülteni, vol.52, no.1, 2018, ss.64 - 69.
AMA çiftci s,KURAN K,DUMAN Z,Yilmaz F,MERT C,durlanık g,ÖNCÜ J,DÜDEN B,BERTAN H,ERÇALIK C,DOĞU B,Terlemez R The Effect of Associated Parkinsonism on Rehabilitation in Stroke Patients: A Case Series. Şişli Etfal Hastanesi Tıp Bülteni. 2018; 52(1): 64 - 69.
Vancouver çiftci s,KURAN K,DUMAN Z,Yilmaz F,MERT C,durlanık g,ÖNCÜ J,DÜDEN B,BERTAN H,ERÇALIK C,DOĞU B,Terlemez R The Effect of Associated Parkinsonism on Rehabilitation in Stroke Patients: A Case Series. Şişli Etfal Hastanesi Tıp Bülteni. 2018; 52(1): 64 - 69.
IEEE çiftci s,KURAN K,DUMAN Z,Yilmaz F,MERT C,durlanık g,ÖNCÜ J,DÜDEN B,BERTAN H,ERÇALIK C,DOĞU B,Terlemez R "The Effect of Associated Parkinsonism on Rehabilitation in Stroke Patients: A Case Series." Şişli Etfal Hastanesi Tıp Bülteni, 52, ss.64 - 69, 2018.
ISNAD çiftci, selda vd. "The Effect of Associated Parkinsonism on Rehabilitation in Stroke Patients: A Case Series". Şişli Etfal Hastanesi Tıp Bülteni 52/1 (2018), 64-69.